Fusion of Enveloped Viruses in Endosomes

Traffic

Volumn 17, Issue 6, 2016, Pages 593-614

  White, Judith M ^a   Whittaker, Gary R ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Enveloped virus; Fuse; Low pH; Membrane; Prime; Proteases; Trigger; Viral fusion protein; Virus entry; Virus receptors

Indexed keywords

GLYCOPROTEIN; HYBRID PROTEIN; MEMBRANE FUSION PROTEIN; PROTEINASE; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN; VIRUS RECEPTOR;

AFRICAN SWINE FEVER VIRUS; CELL SURFACE; CONFORMATIONAL TRANSITION; ENDOCYTOSIS; ENDOSOME; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HOST CELL; HOST PATHOGEN INTERACTION; INFLUENZA VIRUS; INTERNALIZATION; JAAGSIEKTE SHEEP RETROVIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PARAINFLUENZA VIRUS 5; PH; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SARS CORONAVIRUS; SIMIAN HEMORRHAGIC FEVER VIRUS; TICK BORNE ENCEPHALITIS VIRUS; UUKUNIEMI VIRUS; VACCINIA VIRUS; VESICULOVIRUS; VIRUS ENTRY; ANIMAL; GENETICS; HUMAN; METABOLISM; PATHOGENICITY; VIROLOGY; VIRUS;

ANIMALS; ENDOSOMES; HUMANS; VIRAL FUSION PROTEINS; VIRUS INTERNALIZATION; VIRUSES;

EID: 84963657108     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/tra.12389     Document Type: Review

References (271)

1. Helenius A, Kartenbeck J, Simons K, Fries E. On the entry of Semliki forest virus into BHK-21 cells. J Cell Biol 1980;84:404-420.
2. Matlin KS, Reggio H, Helenius A, Simons K. Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol 1981;91:601-613.
3. Marsh M, Helenius A. Adsorptive endocytosis of Semliki Forest virus. J Mol Biol 1980;142:439-454.
4. Marsh M, Bolzau E, Helenius A. Penetration of Semliki Forest virus from acidic prelysosomal vacuoles. Cell 1983;32:931-940.
5. Simons K, Garoff H, Helenius A. How an animal virus gets into and out of its host cell. Sci Am 1982;246:58-66.
6. White J, Helenius A. pH-dependent fusion between the Semliki Forest virus membrane and liposomes. Proc Natl Acad Sci USA 1980;77:3273-3277.
7. White J, Matlin K, Helenius A. Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. J Cell Biol 1981;89:674-679.
8. White J, Kartenbeck J, Helenius A. Membrane fusion activity of influenza virus. EMBO J 1982;1:217.
9. White J, Helenius A, Gething MJ. Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion. Nature 1982;300:658-659.
10. Maeda T, Kawasaki K, Ohnishi S. Interaction of influenza virus hemagglutinin with target membrane lipids is a key step in virus-induced hemolysis and fusion at pH 5.2. Proc Natl Acad Sci USA 1981;78:4133-4137.
11. Quirin K, Eschli B, Scheu I, Poort L, Kartenbeck J, Helenius A. Lymphocytic choriomeningitis virus uses a novel endocytic pathway for infectious entry via late endosomes. Virology 2008;378:21-33.
12. Pasqual G, Rojek JM, Masin M, Chatton J-Y, Kunz S. Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport. PLoS Pathog 2011;7:e1002232.
13. Lozach P-Y, Huotari J, Helenius A. Late-penetrating viruses. Curr Opin Virol 2011;1:35-43.
14. Mercer J, Schelhaas M, Helenius A. Virus entry by endocytosis. Annu Rev Biochem 2010;79:803-833.
15. Grove J, Marsh M. The cell biology of receptor-mediated virus entry. J Cell Biol 2011;195:1071-1082.
16. Cossart P, Helenius A. Endocytosis of viruses and bacteria. Cold Spring Harb Perspect Biol 2014;6:a016972.
17. Amara A, Mercer J. Viral apoptotic mimicry. Nat Rev Microbiol 2015;13:461-469.
18. Mercer J, Helenius A. Gulping rather than sipping: macropinocytosis as a way of virus entry. Curr Opin Microbiol 2012;15:1-10.
19. Matlin KS, Reggio H, Helenius A, Simons K. Pathway of vesicular stomatitis virus entry leading to infection. J Mol Biol 1982;156:609-631.
20. Mercer J, Helenius A. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 2008;320:531-535.
21. Rizopoulos Z, Balistreri G, Kilcher S, Martin CK, Syedbasha M, Helenius A, Mercer J. Vaccinia virus infection requires maturation of macropinosomes. Traffic 2015;16:814-831.
22. Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, Neumann G, Halfmann P, Kawaoka Y. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog 2010;6:e1001121.
23. Saeed MF, Kolokoltsov AA, Albrecht T, Davey RA. Cellular entry of Ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog 2010;6:e1001110.
24. Mulherkar N, Raaben M, la Torre de JC, Whelan SP, Chandran K. The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway. Virology 2011;419:72-83.
25. Krzyzaniak MA, Zumstein MT, Gerez JA, Picotti P, Helenius A. Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the f protein. PLoS Pathog 2013;9:e1003309.
26. Hetzenecker S, Helenius A, Krzyzaniak MA. HCMV induces macropinocytosis for host cell entry in fibroblasts. Traffic 2016;TRA.12355.
27. Rossman JS, Leser GP, Lamb RA. Filamentous influenza virus enters cells via macropinocytosis. J Virol 2012; 86:10950-10960.
28. de Vries E, Tscherne D, Wienholts M. Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog 2011;7:e1001329.
29. Sieczkarski SB, Whittaker GR. Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J Virol 2002;76:10455-10464.
30. Chen C, Zhuang X. Epsin 1 is a cargo-specific adaptor for the clathrin-mediated endocytosis of the influenza virus. Proc Natl Acad Sci USA 2008;105:11790-11795.
31. Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 2009;137:433-444.
32. Cox RG, Mainou BA, Johnson M, Hastings AK, Schuster JE, Dermody TS, Williams JV. Human metapneumovirus is capable of entering cells by fusion with endosomal membranes. PLoS Pathog 2015;11:e1005303.
33. Haid S, Grethe C, Bankwitz D, Grunwald T, Pietschmann T. Identification of a human respiratory syncytial virus (hRSV) cell entry inhibitor by using a novel lentiviral pseudotype (hRSVpp) system. J Virol 2015;90: 3065-3073.
34. Lennartz F, Bayer K, Czerwonka N, Lu Y, Kehr K, Hirz M, Steinmetzer T, Garten W, Herden C. Surface glycoprotein of Borna disease virus mediates virus spread from cell to cell. Cell Microbiol 2016;18:340-354.
35. Clemente R, la Torre de JC. Cell entry of Borna disease virus follows a clathrin-mediated endocytosis pathway that requires Rab5 and microtubules. J Virol 2009;83:10406-10416.
36. Fritz R, Stiasny K, Heinz FX. Identification of specific histidines as pH sensors in flavivirus membrane fusion. J Cell Biol 2008;183:353-361.
37. Misinzo GM, Delputte PL, Nauwynck HJ. Involvement of proteases in porcine reproductive and respiratory syndrome virus uncoating upon internalization in primary macrophages. Vet Res 2008;39:55.
38. Macovei A, Petrareanu C, Lazar C, Florian P, Branza-Nichita N. Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment. J Virol 2013;87:6415-6427.
39. Van Gorp H, Van Breedam W, Delputte PL, Nauwynck HJ. The porcine reproductive and respiratory syndrome virus requires trafficking through CD163-positive early endosomes, but not late endosomes, for productive infection. Arch Virol 2009;154:1939-1943.
40. Hernáez B, Quetglas JI, Dalmau-Mena I, Alonso C. PLOS ONE: Endosomal maturation, Rab7 GTPase and phosphoinositides in African swine fever virus entry. PLoS ONE 2012;7:e48853.
41. Kielian MC, Marsh M, Helenius A. Kinetics of endosome acidification detected by mutant and wild-type Semliki Forest virus. EMBO J 1986;5:3103-3109.
42. Johannsdottir HK, Mancini R, Kartenbeck J, Amato L, Helenius A. Host cell factors and functions involved in vesicular stomatitis virus entry. J Virol 2009;83:440-453.
43. Galloway SE, Reed ML, Russell CJ, Steinhauer DA. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog 2013;9:e1003151.
44. Zaraket H, Bridges OA, Duan S, Baranovich T, Yoon S-W, Reed ML, Salomon R, Webby RJ, Webster RG, Russell CJ. Increased acid stability of the hemagglutinin protein enhances H5N1 influenza virus growth in the upper respiratory tract but is insufficient for transmission in ferrets. J Virol 2013;87:9911-9922.
45. Zaraket H, Bridges OA, Russell CJ. The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus replication and pathogenesis in mice. J Virol 2013;87:4826-4834.
46. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012;486:420-428.
47. Herfst S, Schrauwen EJA, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus ADME, Fouchier RAM. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 2012;336:1534-1541.
48. Russier M, Yang G, Rehg JE, Wong S-S, Mostafa HH, Fabrizio TP, Barman S, Krauss S, Webster RG, Webby RJ, Russell CJ. Molecular requirements for a pandemic influenza virus: an acid-stable hemagglutinin protein. Proc Natl Acad Sci USA 2016;113:1636-1641.
49. Costello DA, Whittaker GR, Daniel S. Variations in pH sensitivity, acid stability, and fusogenicity of three influenza virus H3 subtypes. J Virol 2015;89:350-360.
50. Kielian MC, Helenius A. Role of cholesterol in fusion of Semliki Forest virus with membranes. J Virol 1984;52:281-283.
51. Nieva JL, Bron R, Corver J, Wilschut J. Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane. EMBO J 1994;13:2797-2804.
52. Kleinfelter LM, Jangra RK, Jae LT, Herbert AS, Mittler E, Stiles KM, Wirchnianski AS, Kielian M, Brummelkamp TR, Dye JM, Chandran K. Haploid genetic screen reveals a profound and direct dependence on cholesterol for hantavirus membrane fusion. MBio 2015;6:e00801.
53. Zaitseva E, Yang S-T, Melikov K, Pourmal S, Chernomordik LV. Dengue virus ensures its fusion in late endosomes using compartment-specific lipids. PLoS Pathog 2010;6:e1001131.
54. Matos PM, Marin M, Ahn B, Lam W, Santos NC, Melikyan GB. Anionic lipids are required for vesicular stomatitis virus G protein-mediated single particle fusion with supported lipid bilayers. J Biol Chem 2013;288:12416-12425.
55. Kadlec J, Loureiro S, Abrescia NGA, Stuart DI, Jones IM. The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines. Nat Struct Mol Biol 2008;15:1024-1030.
56. Li Z, Hung C, Paterson RG, Michel F, Fuentes S, Place R, Lin Y, Hogan RJ, Lamb RA, He B. Type II integral membrane protein, TM of J paramyxovirus promotes cell-to-cell fusion. Proc Natl Acad Sci USA 2015;112:12504-12509.
57. Read J, Clancy EK, Sarker M, de Antueno R, Langelaan DN, Parmar HB, Shin K, Rainey JK, Duncan R. Reovirus FAST proteins drive pore formation and syncytiogenesis using a novel helix-loop-helix fusion-inducing lipid packing sensor. PLoS Pathog 2015;11:e1004962.
58. Nunberg JH, York J. The curious case of arenavirus entry, and its inhibition. Viruses 2012;4:83-101.
59. Moss B. Poxvirus cell entry: how many proteins does it take? Viruses 2012;4:688-707.
60. Cooper RS, Heldwein EE. Herpesvirus gB: a finely tuned fusion machine. Viruses 2015;7:6552-6569.
61. Baquero E, Albertini AA, Gaudin Y. Recent mechanistic and structural insights on class III viral fusion glycoproteins. Curr Opin Struct Biol 2015;33:52-60.
62. Sathiyamoorthy K, Jiang J, Hu YX, Rowe CL, Möhl BS, Chen J, Jiang W, Mellins ED, Longnecker R, Zhou ZH, Jardetzky TS. Assembly and architecture of the EBV B cell entry triggering complex. PLoS Pathog 2014;10:e1004309.
63. Gallagher JR, Atanasiu D, Saw WT, Paradisgarten MJ, Whitbeck JC, Eisenberg RJ, Cohen GH. Functional fluorescent protein insertions in herpes simplex virus gB report on gB conformation before and after execution of membrane fusion. PLoS Pathog 2014;10:e1004373.
64. Delgado CL, Núñez E, Yélamos B, Gómez-Gutiérrez J, Peterson DL, Gavilanes F. Spectroscopic characterization and fusogenic properties of preS domains of duck hepatitis B virus. Biochemistry 2012;51:8444-8454.
65. White JM, Delos SE, Brecher M, Schornberg K. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol 2008;43:189-219.
66. Harrison SC. Viral membrane fusion. Virology 2015;479-480C:498-507.
67. Bose S, Jardetzky TS, Lamb RA. Timing is everything: fine-tuned molecular machines orchestrate paramyxovirus entry. Virology 2015;479-480:518-531.
68. Kielian M. Mechanisms of virus membrane fusion proteins. Annu Rev Virol 2014;1:171-189.
69. Plemper RK. Cell entry of enveloped viruses. Curr Opin Virol 2011;1:92-100.
70. Eisenberg RJ, Atanasiu D, Cairns TM, Gallagher JR, Krummenacher C, Cogen GH. Herpes virus fusion and entry: a story with many characters. Viruses 2012;4:800-832.
71. Schmidt FI, Bleck CKE, Mercer J. Poxvirus host cell entry. Curr Opin Virol 2012;2:20-27.
72. Park HE, Gruenke JA, White JM. Leash in the groove mechanism of membrane fusion. Nat Struct Biol 2003;10:1048-1053.
73. Böttcher-Friebertshäuser E, Garten W, Matrosovich M, Klenk H-D. The hemagglutinin: a determinant of pathogenicity. Curr Top Microbiol Immunol 2014;385:3-34.
74. Zmora P, Blazejewska P, Moldenhauer A-S, Welsch K, Nehlmeier I, Wu Q, Schneider H, Pöhlmann S, Bertram S. DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry. J Virol 2014;88:12087-12097.
75. Böttcher-Friebertshäuser E, Klenk H-D, Garten W. Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium. Pathog Dis 2013;69:87-100.
76. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 2005;308:1643-1645.
77. Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, White J. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol 2006;80:4174-4178.
78. Pager CT, Dutch RE. Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. J Virol 2005;79:12714-12720.
79. Pager CT, Craft WW, Patch J, Dutch RE. A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L. Virology 2006;346:251-257.
80. Diederich S, Sauerhering L, Weis M, Altmeppen H, Schaschke N, Reinheckel T, Erbar S, Maisner A. Activation of the Nipah virus fusion protein in MDCK cells is mediated by cathepsin B within the endosome-recycling compartment. J Virol 2012;86:3736-3745.
81. Cao S, Zhang W. Characterization of an early-stage fusion intermediate of Sindbis virus using cryoelectron microscopy. Proc Natl Acad Sci USA 2013;110:13362-13367.
82. Liu CY, Kielian M. E1 mutants identify a critical region in the trimer interface of the Semliki forest virus fusion protein. J Virol 2009;83:11298-11306.
83. Brandenberg OF, Magnus C, Rusert P, Regoes RR, Trkola A. Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entry. PLoS Pathog 2015;11:e1004595.
84. Danieli T, Pelletier SL, Henis YI, White JM. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J Cell Biol 1996;133:559-569.
85. Floyd DL, Ragains JR, Skehel JJ, Harrison SC, van Oijen AM. Single-particle kinetics of influenza virus membrane fusion. Proc Natl Acad Sci USA 2008;105:15382-15387.
86. Xu K, Chan Y-P, Bradel-Tretheway B, Akyol-Ataman Z, Zhu Y, Dutta S, Yan L, Feng Y, Wang L-F, Skiniotis G, Lee B, Zhou ZH, Broder CC, Aguilar HC, Nikolov DB. Crystal structure of the pre-fusion Nipah virus fusion glycoprotein reveals a novel hexamer-of-trimers assembly. PLoS Pathog 2015;11:e1005322.
87. Gibbons DL, Vaney M-C, Roussel A, Vigouroux A, Reilly B, Lepault J, Kielian M, Rey FA. Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature 2004;427:320-325.
88. Chao LH, Klein DE, Schmidt AG, Peña JM, Harrison SC. Sequential conformational rearrangements in flavivirus membrane fusion. Elife 2014;3:e04389.
89. Markovic I, Pulyaeva H, Sokoloff A, Chernomordik LV. Membrane fusion mediated by baculovirus gp64 involves assembly of stable gp64 trimers into multiprotein aggregates. J Cell Biol 1998;143:1155-1166.
90. Libersou S, Albertini AAV, Ouldali M, Maury V, Maheu C, Raux H, de Haas F, Roche S, Gaudin Y, Lepault J. Distinct structural rearrangements of the VSV glycoprotein drive membrane fusion. J Cell Biol 2010;191:199-210.
91. Maurer UE, Zeev-Ben-Mordehai T, Pandurangan AP, Cairns TM, Hannah BP, Whitbeck JC, Eisenberg RJ, Cohen GH, Topf M, Huiskonen JT, Grünewald K. The structure of herpesvirus fusion glycoprotein B-bilayer complex reveals the protein-membrane and lateral protein-protein interaction. Structure 2013;21:1396-1405.
92. Spruce AE, Iwata A, White JM, Almers W. Patch clamp studies of single cell-fusion events mediated by a viral fusion protein. Nature 1989;342:555-558.
93. Chernomordik LV, Kozlov MM. Mechanics of membrane fusion. Nat Struct Mol Biol 2008;15:675-683.
94. Cohen FS, Melikyan GB. The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement. J Membr Biol 2004;199:1-14.
95. Lee KK. Architecture of a nascent viral fusion pore. EMBO J 2010;29:1299-1311.
96. Wilson IA, Skehel JJ, Wiley DC. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 1981;289:366-373.
97. Bullough PA, Hughson FM, Skehel JJ, Wiley DC. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 1994;371:37-43.
98. Tamm LK. Hypothesis: spring-loaded boomerang mechanism of influenza hemagglutinin-mediated membrane fusion. Biochim Biophys Acta 1614;2003:14-23.
99. Lai AL, Freed JH. The interaction between influenza HA fusion peptide and transmembrane domain affects membrane structure. Biophys J 2015;109:2523-2536.
100. Chang D-K, Cheng S-F, Kantchev EAB, Lin C-H, Liu Y-T. Membrane interaction and structure of the transmembrane domain of influenza hemagglutinin and its fusion peptide complex. BMC Biol 2008;6:2.
101. Reuven EM, Dadon Y, Viard M, Manukovsky N, Blumenthal R, Shai Y. HIV-1 gp41 transmembrane domain interacts with the fusion peptide: implication in lipid mixing and inhibition of virus-cell fusion. Biochemistry 2012;51:2867-2878.
102. Vishwanathan SA, Hunter E. Importance of the membrane-perturbing properties of the membrane-proximal external region of human immunodeficiency virus type 1 gp41 to viral fusion. J Virol 2008;82:5118-5126.
103. Howard MW, Travanty EA, Jeffers SA, Smith MK, Wennier ST, Thackray LB, Holmes KV. Aromatic amino acids in the juxtamembrane domain of severe acute respiratory syndrome coronavirus spike glycoprotein are important for receptor-dependent virus entry and cell-cell fusion. J Virol 2008;82:2883-2894.
104. Tong S, Yi F, Martin A, Yao Q, Li M, Compans RW. Three membrane-proximal amino acids in the human parainfluenza type 2 (HPIV 2) F protein are critical for fusogenic activity. Virology 2001;280:52-61.
105. Jeetendra E, Ghosh K, Odell D, Li J, Ghosh HP, Whitt MA. The membrane-proximal region of vesicular stomatitis virus glycoprotein G ectodomain is critical for fusion and virus infectivity. J Virol 2003;77:12807-12818.
106. Backovic M, Jardetzky TS, Longnecker R. Hydrophobic residues that form putative fusion loops of Epstein-Barr virus glycoprotein B are critical for fusion activity. J Virol 2007;81:9596-9600.
107. Baquero E, Albertini AA, Raux H, Buonocore L, Rose JK, Bressanelli S, Gaudin Y. Structure of the low pH conformation of Chandipura virus G reveals important features in the evolution of the vesiculovirus glycoprotein. PLoS Pathog 2015;11:e1004756.
108. Madu IG, Roth SL, Belouzard S, Whittaker GR. Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide. J Virol 2009;83:7411-7421.
109. Walls AC, Tortorici MA, Bosch BJ, Frenz B, Rottier PJM, DiMaio F, Rey FA, Veesler D. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. Nature 2016;531:114-117.
110. Kirchdoerfer RN, Cotrell CA, Wang N, Pallesen J, Yassine HM, Turner HL, Corbett KS, Graham BS, McLellan JS, Ward AB. Pre-fusion structure of a human coronavirus spike protein. Nature 2016;531:118-121.
111. Lai AL, Park H, White JM, Tamm LK. Fusion peptide of influenza hemagglutinin requires a fixed angle boomerang structure for activity. J Biol Chem 2006;281:5760-5770.
112. Lorieau JL, Louis JM, Schwieters CD, Bax A. pH-triggered, activated-state conformations of the influenza hemagglutinin fusion peptide revealed by NMR. Proc Natl Acad Sci USA 2012;109:19994-19999.
113. Lai AL, Moorthy AE, Li Y, Tamm LK. Fusion activity of HIV gp41 fusion domain is related to its secondary structure and depth of membrane insertion in a cholesterol-dependent fashion. J Mol Biol 2012;418:3-15.
114. Qiang W, Sun Y, Weliky DP. A strong correlation between fusogenicity and membrane insertion depth of the HIV fusion peptide. Proc Natl Acad Sci 2009;106:15314-15319.
115. Haque ME, Koppaka V, Axelsen PH, Lentz BR. Properties and structures of the influenza and HIV fusion peptides on lipid membranes: implications for a role in fusion. Biophys J 2005;89:3183-3194.
116. Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, Saphire EO. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 2008;454:177-182.
117. Gregory SM, Harada E, Liang B, Delos SE, White JM, Tamm LK. Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2. Proc Natl Acad Sci USA 2011;108:11211-11216.
118. Han X, Bushweller JH, Cafiso DS, Tamm LK. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat Struct Biol 2001;8:715-720.
119. Li Y, Han X, Lai AL, Bushweller JH, Cafiso DS, Tamm LK. Membrane structures of the hemifusion-inducing fusion peptide mutant G1S and the fusion-blocking mutant G1V of influenza virus hemagglutinin suggest a mechanism for pore opening in membrane fusion. J Virol 2005;79:12065-12076.
120. Qiao H, Armstrong RT, Melikyan GB, Cohen FS, White JM. A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Mol Biol Cell 1999;10:2759-2769.
121. Gregory SM, Larsson P, Nelson EA, Kasson PM, White JM, Tamm LK. Ebolavirus entry requires a compact hydrophobic fist at the tip of the fusion loop. J Virol 2014;88:6636-6649.
122. Modis Y, Ogata S, Clements D, Harrison SC. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004;427:313-319.
123. Kanai R, Kar K, Anthony K, Gould LH, Ledizet M, Fikrig E, Marasco WA, Koski RA, Modis Y. Crystal structure of west Nile virus envelope glycoprotein reveals viral surface epitopes. J Virol 2006;80:11000-11008.
124. Bressanelli S, Stiasny K, Allison SL, Stura EA, Duquerroy S, Lescar J, Heinz FX, Rey FA. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J 2004;23:728-738.
125. Cifuentes-Muñoz N, Salazar-Quiroz N, Tischler ND. Hantavirus Gn and Gc envelope glycoproteins: key structural units for virus cell entry and virus assembly. Viruses 2014;6:1801-1822.
126. Roche S, Rey FA, Gaudin Y, Bressanelli S. Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G. Science 2007;315:843-848.
127. Sun X, Belouzard S, Whittaker GR. Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein. J Biol Chem 2008;283:6418-6427.
128. Dubé M, Rey FA, Kielian M. Rubella virus: first calcium-requiring viral fusion protein. PLoS Pathog 2014;10:e1004530.
129. DuBois RM, Vaney M-C, Tortorici MA, Kurdi RA, Barba-Spaeth G, Krey T, Rey FA. Functional and evolutionary insight from the crystal structure of rubella virus protein E1. Nature 2013;493:552-556.
130. Hannah BP, Heldwein EE, Bender FC, Cohen GH, Eisenberg RJ. Mutational evidence of internal fusion loops in herpes simplex virus glycoprotein B. J Virol 2007;81:4858-4865.
131. Heldwein EE, Lou H, Bender FC, Cohen GH, Eisenberg RJ, Harrison SC. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 2006;313:217-220.
132. Backovic M, Longnecker R, Jardetzky TS. Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B. Proc Natl Acad Sci USA 2009;106:2880-2885.
133. Melikyan GB. HIV entry: a game of hide-and-fuse? Curr Opin Virol 2014;4:1-7.
134. Hulme AE, Hope TJ. Live cell imaging of retroviral entry. Annu Rev Virol 2014;1:501-515.
135. Chu VC, McElroy LJ, Chu V, Bauman BE, Whittaker GR. The avian coronavirus infectious bronchitis virus undergoes direct low-pH-dependent fusion activation during entry into host cells. J Virol 2006;80:3180-3188.
136. Schowalter RM, Chang A, Robach JG, Buchholz UJ, Dutch RE. Low-pH triggering of human metapneumovirus fusion: essential residues and importance in entry. J Virol 2009;83:1511-1522.
137. Yun B, Guan X, Liu Y, Gao Y, Wang Y, Qi X, Cui H, Liu C, Zhang Y, Gao L, Li K, Gao H, Gao Y, Wang X. Trypsin- and low pH-mediated fusogenicity of avian metapneumovirus fusion proteins is determined by residues at positions 100, 101 and 294. Sci Rep 2015;5:15584.
138. Wilen CB, Tilton JC, Doms RW. HIV: cell binding and entry. Cold Spring Harb Perspect Med 2012;2:a006866.
139. Mothes W, Boerger AL, Narayan S, Cunningham JM, Young JA. Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell 2000;103:679-689.
140. Matsuyama S, Delos SE, White JM. Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein. J Virol 2004;78:8201-8209.
141. Melikyan GB, Barnard RJO, Markosyan RM, Young JAT, Cohen FS. Low pH is required for avian sarcoma and leukosis virus Env-induced hemifusion and fusion pore formation but not for pore growth. J Virol 2004;78:3753-3762.
142. Melikyan GB, Barnard RJO, Abrahamyan LG, Mothes W, Young JAT. Imaging individual retroviral fusion events: from hemifusion to pore formation and growth. Proc Natl Acad Sci USA 2005;102:8728-8733.
143. Dollery SJ, Wright CC, Johnson DC, Nicola AV. Low-pH-dependent changes in the conformation and oligomeric state of the prefusion form of herpes simplex virus glycoprotein B are separable from fusion activity. J Virol 2011;85:9964-9973.
144. Maeda T, Ohnishi S. Activation of influenza virus by acidic media causes hemolysis and fusion of erythrocytes. FEBS Lett 1980;122:283-287.
145. Huang RT, Rott R, Klenk HD. Influenza viruses cause hemolysis and fusion of cells. Virology 1981;110:243-247.
146. Skehel JJ, Bayley PM, Brown EB, Martin SR, Waterfield MD, White JM, Wilson IA, Wiley DC. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci USA 1982;79:968-972.
147. Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 2000;69:531-569.
148. White JM, Wilson IA. Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. J Cell Biol 1987;105:2887-2896.
149. Daniels RS, Downie JC, Hay AJ, Knossow M, Skehel JJ, Wang ML, Wiley DC. Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell 1985;40:431-439.
150. Thoennes S, Li Z-N, Lee B-J, Langley WA, Skehel JJ, Russell RJ, Steinhauer DA. Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion. Virology 2008;370:403-414.
151. Mair CM, Meyer T, Schneider K, Huang Q, Veit M, Herrmann A. A histidine residue of the influenza virus hemagglutinin controls the pH dependence of the conformational change mediating membrane fusion. J Virol 2014;88:13189-13200.
152. Delos SE, La B, Gilmartin A, White JM. Studies of the "chain reversal regions" of the avian sarcoma/leukosis virus (ASLV) and ebolavirus fusion proteins: analogous residues are important, and a His residue unique to EnvA affects the pH dependence of ASLV entry. J Virol 2010;84:5687-5694.
153. Kalani MR, Moradi A, Moradi M, Tajkhorshid E. Characterizing a histidine switch controlling pH-dependent conformational changes of the influenza virus hemagglutinin. Biophys J 2013;105:993-1003.
154. Zheng Y, Sánchez-San Martín C, Qin Z-L, Kielian M. The domain I-domain III linker plays an important role in the fusogenic conformational change of the alphavirus membrane fusion protein. J Virol 2011;85:6334-6342.
155. Nayak V, Dessau M, Kucera K, Anthony K, Ledizet M, Modis Y. Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J Virol 2009;83:4338-4344.
156. Nelson S, Poddar S, Lin T-Y, Pierson TC. Protonation of individual histidine residues is not required for the pH-dependent entry of west nile virus: evaluation of the "histidine switch" hypothesis. J Virol 2009;83:12631-12635.
157. de Boer SM, Kortekaas J, Spel L, Rottier PJM, Moormann RJM, Bosch BJ. Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein. J Virol 2012;86:13642-13652.
158. Dessau M, Modis Y. Crystal structure of glycoprotein C from Rift Valley fever virus. Proc Natl Acad Sci USA 2013;110:1696-1701.
159. Zheng A, Yuan F, Kleinfelter LM, Kielian M. A toggle switch controls the low pH-triggered rearrangement and maturation of the dengue virus envelope proteins. Nat Commun 2014;5:3877.
160. Carneiro FA, Stauffer F, Lima CS, Juliano MA, Juliano L, Da Poian AT. Membrane fusion induced by vesicular stomatitis virus depends on histidine protonation. J Biol Chem 2003;278:13789-13794.
161. Li Z, Blissard GW. Autographa californica multiple nucleopolyhedrovirus GP64 protein: roles of histidine residues in triggering membrane fusion and fusion pore expansion. J Virol 2011;85:12492-12504.
162. Rachakonda PS, Veit M, Korte T, Ludwig K, Böttcher C, Huang Q, Schmidt MFG, Herrmann A. The relevance of salt bridges for the stability of the influenza virus hemagglutinin. FASEB J 2007;21:995-1002.
163. Garcia NK, Guttman M, Ebner JL, Lee KK. Dynamic changes during acid-induced activation of influenza hemagglutinin. Structure 2015;23:665-676.
164. Mueller DS, Kampmann T, Yennamalli R, Young PR, Kobe B, Mark AE. Histidine protonation and the activation of viral fusion proteins. Biochem Soc Trans 2008;36:43-45.
165. Ivanovic T, Rozendaal R, Floyd DL, Popovic M, van Oijen AM, Harrison SC. Kinetics of proton transport into influenza virions by the viral M2 channel. PLoS One 2012;7:e31566.
166. Wang J, Wu Y, Ma C, Fiorin G, Wang J, Pinto LH, Lamb RA, Klein ML, Degrado WF. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus. Proc Natl Acad Sci USA 2013;110:1315-1320.
167. Batishchev OV, Shilova LA, Kachala MV, Tashkin VY, Sokolov VS, Fedorova NV, Baratova LA, Knyazev DG, Zimmerberg J, Chizmadzhev YA. pH-dependent formation and disintegration of the influenza A virus protein scaffold to provide tension for membrane fusion. J Virol 2015;90:575-585.
168. Fontana J, Steven AC. At low pH, influenza virus matrix protein M1 undergoes a conformational change prior to dissociating from the membrane. J Virol 2013;87:5621-5628.
169. Stauffer S, Feng Y, Nebioglu F, Heilig R, Picotti P, Helenius A. Stepwise priming by acidic pH and a high K+ concentration is required for efficient uncoating of influenza A virus cores after penetration. J Virol 2014;88:13029-13046.
170. Mire C, Dube D, Delos S, White J. Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix protein. J Virol 2009;83:12139-12150.
171. Hover S, King B, Hall B, Loundras E-A, Taqi H, Daly J, Dallas M, Peers C, Schnettler E, McKimmie C, Kohl A, Barr JN, Mankouri J. Modulation of potassium channels inhibits bunyavirus infection. J Biol Chem 2016;291:3411-3422.
172. Bron R, Wahlberg JM, Garoff H, Wilschut J. Membrane fusion of Semliki Forest virus in a model system: correlation between fusion kinetics and structural changes in the envelope glycoprotein. EMBO J 1993;12:693-701.
173. Umashankar M, Sánchez-San Martín C, Liao M, Reilly B, Guo A, Taylor G, Kielian M. Differential cholesterol binding by class II fusion proteins determines membrane fusion properties. J Virol 2008;82:9245-9253.
174. van der Schaar HM, Rust MJ, Chen C, van der Ende-Metselaar H, Wilschut J, Zhuang X, Smit JM. Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog 2008;4:e1000244.
175. Nour AM, Li Y, Wolenski J, Modis Y. Viral membrane fusion and nucleocapsid delivery into the cytoplasm are distinct events in some flaviviruses. PLoS Pathog 2013;9:e1003585.
176. Esposito DLA, Nguyen JB, DeWitt DC, Rhoades E, Modis Y. Physico-chemical requirements and kinetics of membrane fusion of flavivirus-like particles. J Gen Virol 2015;96:1702-1711.
177. Roth SL, Whittaker GR. Promotion of vesicular stomatitis virus fusion by the endosome-specific phospholipid bis(monoacylglycero)phosphate (BMP). FEBS Lett 2011;585:865-869.
178. Le Blanc I, Luyet P-P, Pons V, Ferguson C, Emans N, Petiot A, Mayran N, Demaurex N, Fauré J, Sadoul R, Parton RG, Gruenberg J. Endosome-to-cytosol transport of viral nucleocapsids. Nat Cell Biol 2005;7:653-664.
179. Bitto D, Halldorsson S, Caputo A, Huiskonen JT. Low pH and anionic lipid dependent fusion of Uukuniemi phlebovirus to liposomes. J Biol Chem 2016;M115.691113.
180. Wallin M, Ekström M, Garoff H. Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion. EMBO J 2004;23:54-65.
181. Li K, Zhang S, Kronqvist M, Wallin M, Ekström M, Derse D, Garoff H. Intersubunit disulfide isomerization controls membrane fusion of human T-cell leukemia virus Env. J Virol 2008;82:7135-7143.
182. Tran EEH, Borgnia MJ, Kuybeda O, Schauder DM, Bartesaghi A, Frank GA, Sapiro G, Milne JLS, Subramaniam S. Structural mechanism of trimeric HIV-1 envelope glycoprotein activation. PLoS Pathog 2012;8:e1002797.
183. Munro JB, Gorman J, Ma X, Zhou Z, Arthos J, Burton DR, Koff WC, Courter JR, Smith AB, Kwong PD, Blanchard SC, Mothes W. Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions. Science 2014;346:759-763.
184. Chen B, Vogan EM, Gong H, Skehel JJ, Wiley DC, Harrison SC. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 2005;433:834-841.
185. Jardetzky TS, Lamb RA. Activation of paramyxovirus membrane fusion and virus entry. Curr Opin Virol 2014;5:24-33.
186. Wong JJW, Paterson RG, Lamb RA, Jardetzky TS. Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form. Proc Natl Acad Sci USA 2016;113:1056-1061.
187. Delos SE, Godby JA, White JM. Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation. J Virol 2005;79:3488-3499.
188. Smith JG, Cunningham JM. Receptor-induced thiolate couples Env activation to retrovirus fusion and infection. PLoS Pathog 2007;3:e198.
189. Hernandez LD, Peters RJ, Delos SE, Young JA, Agard DA, White JM. Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein. J Cell Biol 1997;139:1455-1464.
190. Hernandez LD, White JM. Mutational analysis of the candidate internal fusion peptide of the avian leukosis and sarcoma virus subgroup A envelope glycoprotein. J Virol 1998;72:3259-3267.
191. Damico RL, Crane J, Bates P. Receptor-triggered membrane association of a model retroviral glycoprotein. Proc Natl Acad Sci USA 1998;95:2580-2585.
192. Cardone G, Brecher M, Fontana J, Winkler DC, Butan C, White JM, Steven AC. Visualization of the two-step fusion process of the retrovirus avian sarcoma/leukosis virus by cryo-electron tomography. J Virol 2012;86:12129-12137.
193. Markosyan RM, Bates P, Cohen FS, Melikyan GB. A study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle. Biophys J 2004;87:3291-3298.
194. Netter RC, Amberg SM, Balliet JW, Biscone MJ, Vermeulen A, Earp LJ, White JM, Bates P. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate. J Virol 2004;78:13430-13439.
195. Padilla-Parra S, Marin M, Kondo N, Melikyan GB. Synchronized retrovirus fusion in cells expressing alternative receptor isoforms releases the viral core into distinct sub-cellular compartments. PLoS Pathog 2012;8:e1002694.
196. Aydin H, Smrke BM, Lee JE. Structural characterization of a fusion glycoprotein from a retrovirus that undergoes a hybrid 2-step entry mechanism. FASEB J 2013;27:5059-5071.
197. Côté M, Zheng Y-M, Liu S-L. Receptor binding and low pH coactivate oncogenic retrovirus envelope-mediated fusion. J Virol 2009;83:11447-11455.
198. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G, Dal Cin P, Dye JM, Whelan SP, Chandran K, Brummelkamp TR. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 2011;477:340-343.
199. Jae LT, Raaben M, Herbert AS, Kuehne AI, Wirchnianski AS, Soh TK, Stubbs SH, Janssen H, Damme M, Saftig P, Whelan SP, Dye JM, Brummelkamp TR. Lassa virus entry requires a trigger-induced receptor switch. Science 2014;344:1506-1510.
200. Jae LT, Brummelkamp TR. Emerging intracellular receptors for hemorrhagic fever viruses. Trends Microbiol 2015;23:392-400.
201. Li S, Sun Z, Pryce R, Parsy M-L, Fehling SK, Schlie K, Siebert CA, Garten W, Bowden TA, Strecker T, Huiskonen JT. Acidic pH-induced conformations and LAMP1 binding of the Lassa virus glycoprotein spike. PLoS Pathog 2016;12:e1005418.
202. Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci USA 2004;101:4240-4245.
203. Simmons G. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci USA 2005;102:11876-11881.
204. Bosch BJ, Bartelink W, Rottier PJM. Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide. J Virol 2008;82:8887-8890.
205. Matsuyama S, Ujike M, Morikawa S, Tashiro M, Taguchi F. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc Natl Acad Sci USA 2005;102:12543-12547.
206. Li F, Berardi M, Li W, Farzan M, Dormitzer PR, Harrison SC. Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain. J Virol 2006;80:6794-6800.
207. Bertram S, Glowacka I, Müller MA, Lavender H, Gnirss K, Nehlmeier I, Niemeyer D, He Y, Simmons G, Drosten C, Soilleux EJ, Jahn O, Steffen I, Pöhlmann S. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol 2011;85:13363-13372.
208. Belouzard S, Chu VC, Whittaker GR. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci USA 2009;106:5871-5876.
209. Millet JK, Whittaker GR. Host cell proteases: critical determinants of coronavirus tropism and pathogenesis. Virus Res 2015;202:120-134.
210. Gierer S, Bertram S, Kaup F, Wrensch F, Heurich A, Krämer-Kühl A, Welsch K, Winkler M, Meyer B, Drosten C, Dittmer U, Hahn von T, Simmons G, Hofmann H, Pöhlmann S. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol 2013;87:5502-5511.
211. Shirato K, Kawase M, Matsuyama S. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J Virol 2013;87:12552-12561.
212. Qian Z, Dominguez SR, Holmes KV. Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation. PLoS One 2013;8:e76469.
213. Millet JK, Whittaker GR. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc Natl Acad Sci USA 2014;111:15214-15219.
214. Burkard C, Verheije MH, Wicht O, van Kasteren SI, van Kuppeveld FJ, Haagmans BL, Pelkmans L, Rottier PJM, Bosch BJ, de Haan CAM. Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner. PLoS Pathog 2014;10:e1004502.
215. Sjöberg M, Lindqvist B, Garoff H. Activation of the alphavirus spike protein is suppressed by bound E3. J Virol 2011;85:5644-5650.
216. de Haan CAM, Stadler K, Godeke G-J, Bosch BJ, Rottier PJM. Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion. J Virol 2004;78:6048-6054.
217. Licitra BN, Millet JK, Regan AD, Hamilton BS, Rinaldi VD, Duhamel GE, Whittaker GR. Mutation in spike protein cleavage site and pathogenesis of feline coronavirus. Emerg Infect Dis 2013;19:1066-1073.
218. Le Coupanec A, Desforges M, Meessen-Pinard M, Dubé M, Day R, Seidah NG, Talbot PJ. Cleavage of a neuroinvasive human respiratory virus spike glycoprotein by proprotein convertases modulates neurovirulence and virus spread within the central nervous system. PLoS Pathog 2015;11:e1005261.
219. Licitra BN, Sams KL, Lee DW, Whittaker GR. Feline coronaviruses associated with feline infectious peritonitis have modifications to spike protein activation sites at two discrete positions. arXiv 2014:1412.4034.
220. Wicht O, Burkard C, de Haan CAM, van Kuppeveld FJM, Rottier PJM, Bosch BJ. Identification and characterization of a proteolytically primed form of the murine coronavirus spike proteins after fusion with the target cell. J Virol 2014;88:4943-4952.
221. Wicht O, Li W, Willems L, Meuleman TJ, Wubbolts RW, van Kuppeveld FJM, Rottier PJM, Bosch BJ. Proteolytic activation of the porcine epidemic diarrhea coronavirus spike fusion protein by trypsin in cell culture. J Virol 2014;88:7952-7961.
222. Yamada Y, Liu DX. Proteolytic activation of the spike protein at a novel RRRR/S motif is implicated in furin-dependent entry, syncytium formation, and infectivity of coronavirus infectious bronchitis virus in cultured cells. J Virol 2009;83:8744-8758.
223. Edinger TO, Pohl MO, Yángüez E, Stertz S. Cathepsin W is required for escape of influenza A virus from late endosomes. MBio 2015;6:e00297.
224. White JM, Schornberg KL. A new player in the puzzle of filovirus entry. Nat Rev Microbiol 2012;10:317-322.
225. Hofmann-Winkler H, Kaup F, Pöhlmann S. Host cell factors in filovirus entry: novel players, new insights. Viruses 2012;4:3336-3362.
226. Hunt CL, Lennemann NJ, Maury W. Filovirus entry: a novelty in the viral fusion world. Viruses 2012;4:258-275.
227. Miller EH, Chandran K. Filovirus entry into cells - new insights. Curr Opin Virol 2012;2:206-214.
228. Miller EH, Obernosterer G, Raaben M, Herbert AS, Deffieu MS, Krishnan A, Ndungo E, Sandesara RG, Carette JE, Kuehne AI, Ruthel G, Pfeffer SR, Dye JM, Whelan SP, Brummelkamp TR, et al. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J 2012;31:1947-1960.
229. Mingo RM, Simmons JA, Shoemaker CJ, Nelson EA, Schornberg KL, D'Souza RS, Casanova JE, White JM. Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step. J Virol 2015;89:2931-2943.
230. Simmons JA, D'Souza RS, Ruas M, Galione A, Casanova JE, White JM. Ebolavirus glycoprotein directs fusion through NPC1+ endolysosomes. J Virol 2016;90:605-610.
231. Côté M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM, Hensley L, Li Q, Ory D, Chandran K, Cunningham J. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 2011;477:344-348.
232. Sakurai Y, Kolokoltsov AA, Chen C-C, Tidwell MW, Bauta WE, Klugbauer N, Grimm C, Wahl-Schott C, Biel M, Davey RA. Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science 2015;347:995-998.
233. Spence JS, Krause TB, Mittler E, Jangra RK, Chandran K. Direct visualization of Ebola virus fusion triggering in the endocytic pathway. MBio 2016;7:e01857-15.
234. Tran EEH, Simmons JA, Bartesaghi A, Shoemaker CJ, Nelson E, White JM, Subramaniam S. Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography. J Virol 2014;88:10958-10962.
235. Dube D, Brecher MB, Delos SE, Rose SC, Park EW, Schornberg KL, Kuhn JH, White JM. The primed ebolavirus glycoprotein (19-kilodalton GP1, 2): sequence and residues critical for host cell binding. J Virol 2009;83:2883-2891.
236. Brecher M, Schornberg KL, Delos SE, Fusco ML, Saphire EO, White JM. Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change. J Virol 2012;86:364-372.
237. Bale S, Liu T, Li S, Wang Y, Abelson D, Fusco M, Woods VL, Saphire EO. Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion. PLoS Negl Trop Dis 2011;5:e1395.
238. Wong AC, Sandesara RG, Mulherkar N, Whelan SP, Chandran K. A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry. J Virol 2010;84:163-175.
239. Harrison JS, Higgins CD, Chandran K, Lai JR. Designed protein mimics of the Ebola virus glycoprotein GP2 α-helical bundle: stability and pH effects. Protein Sci 2011;20:1587-1596.
240. Harrison JS, Koellhoffer JF, Chandran K, Lai JR. Marburg virus glycoprotein GP2: pH-dependent stability of the ectodomain α-helical bundle. Biochemistry 2012;51:2515-2525.
241. Koellhoffer JF, Malashkevich VN, Harrison JS, Toro R, Bhosle RC, Chandran K, Almo SC, Lai JR. Crystal structure of the Marburg virus GP2 core domain in its postfusion conformation. Biochemistry 2012;51:7665-7675.
242. Markosyan RM, Miao C, Zheng Y-M, Melikyan GB, Liu S-L, Cohen FS. Induction of cell-cell fusion by Ebola virus glycoprotein: low pH is not a trigger. PLoS Pathog 2016;12:e1005373.
243. Wang H, Shi Y, Song J, Qi J, Lu G, Yan J, Gao GF. Ebola viral glycoprotein bound to its endosomal receptor Niemann-Pick C1. Cell 2016;164:258-268.
244. Bartosch B, Dubuisson J, Cosset FL. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 2003;197:633-642.
245. Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, McKeating JA. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA 2003;100:7271-7276.
246. Petracca R, Falugi F, Galli G, Norais N, Rosa D, Campagnoli S, Burgio V, Di Stasio E, Giardina B, Houghton M, Abrignani S, Grandi G. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J Virol 2000;74:4824-4830.
247. Wang Z, Nie Y, Wang P, Ding M, Deng H. Characterization of classical swine fever virus entry by using pseudotyped viruses: E1 and E2 are sufficient to mediate viral entry. Virology 2004;330:332-341.
248. Douam F, Dao Thi VL, Maurin G, Fresquet J, Mompelat D, Zeisel MB, Baumert TF, Cosset F-L, Lavillette D. Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry. Hepatology 2014;59:776-788.
249. Douam F, Lavillette D, Cosset F-L. The mechanism of HCV entry into host cells. Prog Mol Biol Transl Sci 2015;129:63-107.
250. Fénéant L, Potel J, François C, Sané F, Douam F, Belouzard S, Calland N, Vausselin T, Rouillé Y, Descamps V, Baumert TF, Duverlie G, Lavillette D, Hober D, Dubuisson J, et al. New insights into the understanding of hepatitis C virus entry and cell-to-cell transmission by using the ionophore monensin A. J Virol 2015;89:8346-8364.
251. Li Y, Wang J, Kanai R, Modis Y. Crystal structure of glycoprotein E2 from bovine viral diarrhea virus. Proc Natl Acad Sci USA 2013;110:6805-6810.
252. Omari El K, Iourin O, Harlos K, Grimes JM, Stuart DI. Structure of a pestivirus envelope glycoprotein e2 clarifies its role in cell entry. Cell Rep 2013;3:30-35.
253. Kong L, Giang E, Nieusma T, Kadam RU, Cogburn KE, Hua Y, Dai X, Stanfield RL, Burton DR, Ward AB, Wilson IA, Law M. Hepatitis C virus E2 envelope glycoprotein core structure. Science 2013;342:1090-1094.
254. Khan AG, Whidby J, Miller MT, Scarborough H, Zatorski AV, Cygan A, Price AA, Yost SA, Bohannon CD, Jacob J, Grakoui A, Marcotrigiano J. Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2. Nature 2014;509:381-384.
255. Drummer HE, Boo I, Poumbourios P. Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1. J Gen Virol 2007;88:1144-1148.
256. Li H-F, Huang C-H, Ai L-S, Chuang C-K, Chen SSL. Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entry. J Biomed Sci 2009;16:89.
257. Perin PM, Haid S, Brown RJP, Doerrbecker J, Schulze K, Zeilinger C, Schaewen von M, Heller B, Vercauteren K, Luxenburger E, Baktash YM, Vondran FWR, Speerstra S, Awadh A, Mukhtarov F, et al. Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1. Hepatology 2016;63:49-62.
258. Omari El K, Iourin O, Kadlec J, Sutton G, Harlos K, Grimes JM, Stuart DI. Unexpected structure for the N-terminal domain of hepatitis C virus envelope glycoprotein E1. Nat Commun 2014;5:4874.
259. Meertens L, Bertaux C, Dragic T. Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J Virol 2006;80:11571-11578.
260. Tscherne DM, Jones CT, Evans MJ, Lindenbach BD, McKeating JA, Rice CM. Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J Virol 2006;80:1734-1741.
261. Boo I, teWierik K, Douam F, Lavillette D, Poumbourios P, Drummer HE. Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2. Biochem J 2012;443:85-94.
262. Krey T, Thiel H-J, Rümenapf T. Acid-resistant bovine pestivirus requires activation for pH-triggered fusion during entry. J Virol 2005;79:4191-4200.
263. Sharma NR, Mateu G, Dreux M, Grakoui A, Cosset FL, Melikyan GB. Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion. J Biol Chem 2011;286:30361-30376.
264. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. Binding of hepatitis C virus to CD81. Science 1998;282:938-941.
265. Fénéant L, Levy S, Cocquerel L. CD81 and hepatitis C virus (HCV) infection. Viruses 2014;6:535-572.
266. Holm CK, Jensen SB, Jakobsen MR, Cheshenko N, Horan KA, Moeller HB, Gonzalez-Dosal R, Rasmussen SB, Christensen MH, Yarovinsky TO, Rixon FJ, Herold BC, Fitzgerald KA, Paludan SR. Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING. Nat Immunol 2012;13:737-743.
267. 2+ signalling and incoming genome sensing are required for the host response to low-level enveloped virus particle entry. J Virol 2015;90:3018-3027.
268. Bailey CC, Zhong G, Huang I-C, Farzan M. IFITM-family proteins: the cell's first line of antiviral defense. Annu Rev Virol 2014;1:261-283.
269. Rosa A, Chande A, Ziglio S, De Sanctis V, Bertorelli R, Goh SL, McCauley SM, Nowosielska A, Antonarakis SE, Luban J, Santoni FA, Pizzato M. HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation. Nature 2015;526:212-217.
270. Usami Y, Wu Y, Göttlinger HG. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature 2015;526:218-223.
271. Vigant F, Santos NC, Lee B. Broad-spectrum antivirals against viral fusion. Nat Rev Microbiol 2015;13:426-437.